3 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow ONO-8539: new trials by email Literature Review of ONO-8539 trials Research Report on ONO-8539
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Effect of ONO-8539 on Acid-Induced Oesophageal Hypersensitivity in Healthy Volunteers ONO-8539, Placebo - Acid Reflux | Phase 1 | Completed | Ono Pharmaceutical Co., Ltd. | 20 | 2013-01-01 | 2014-07-08 |
| A Study of the Effect of ONO-8539 on Oesophageal Pain Hypersensitivity in Patients With Non-erosive Reflux Disease ONO-8539, Placebo - GERD | Phase 1 | Completed | Ono Pharmaceutical Co., Ltd. | 14 | 2012-12-01 | 2015-10-14 |
| Study of ONO-8539 in Patients With Overactive Bladder Placebo, Tolterodine, ONO-8539 - Overactive Bladder | Phase 2 | Completed | Ono Pharmaceutical Co., Ltd. | 435 | 2009-04-01 | 2012-06-14 |
Gastroesophageal Reflux (2) · Urinary Bladder, Overactive (1)
Ono Pharmaceutical Co., Ltd. (3)
United Kingdom (2) · Belgium (1) · Czechia (1) · Germany (1) · Hungary (1) · Netherlands (1) · Poland (1) · Romania (1) · Russia (1) · Sweden (1) · Ukraine (1)